Today's pre-market stock movers: BNTX, JPM, RIVN, HPQ and more
•
$COMPASS Pathways (CMPS.US)$ +4.7% (COMPASS Pathways presents largest ever study of psilocybin therapy at American Psychiatric Association annual meeting)
•
$Canoo (GOEV.US)$ +3.5% (files for 48043111 share common stock offering by selling shareholder)
•
$Parsons (PSN.US)$ +3.4% (entered into a definitive agreement to acquire Xator Corporation in a transaction valued at $400 mln)
•
$Guardant Health (GH.US)$ +2.1% (Presents New Data Showing Blood Test Accuracy in Detecting Colorectal Cancer in First-of-its Kind Prospective Study at Digestive Disease Week 2022)
•
$BioNTech (BNTX.US)$ +1.9% (Pfizer/BioNTech (BNTX) COVID-19 vaccine demonstrates strong immune response high efficacy and favorable safety in children 6 months to under 5 years of age following third dose)
•
$Vonage (VG.US)$ +1% (announces that termination date of previously announced deal for ERIC to acquire VG has been extended to August 22)
•
$Vir Biotechnology (VIR.US)$ -2.7% (terminates collaboration agreement with WuXi Bio; other existing agreements between co and WuXi Bio remain in effect)
•
$Cable One (CABO.US)$ -1.8% (authorizes additional repurchases of up to $450 million of Cable One's common stock)
•
$Ocugen (OCGN.US)$ -1.3% (FDA removes clinical hold on phase 2/3 clinical trial for COVAXIN)
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more